Viatris VTRS
NASDAQ VTRS
$16.46 -0.15 (-0.90%)
As of: Sep 9, 2026 · 3:09 PM EDT

Viatris (VTRS) Change in Receivables (2020 - 2026)

Viatris (VTRS) posted Change in Receivables of $126.5 million for Q2 2026, little changed on a QoQ basis from $126.3 million in Q1 2026, and up 1217.71% year-over-year from $9.6 million in Q2 2025.

Analysis

Viatris (VTRS) Change in Receivables (2020 - 2026) Analysis & Trends

Viatris has reported Change in Receivables for 7 years, with the latest figure at $126.5 million in Q2 2026.

  • On a quarterly basis, Change in Receivables rose 1217.71% year-over-year to $126.5 million in Q2 2026; TTM through Jun 2026 was $76.6 million, a 117.99% increase from a year earlier, with the FY2025 full-year figure at -$334.6 million, down 11.5% from the prior year.
  • Change in Receivables was $126.5 million for Q2 2026 at Viatris, roughly flat from $126.3 million in the prior quarter.
  • The five-year high for Change in Receivables was $339.2 million in Q4 2022, with the low at -$300.5 million in Q4 2024.
  • Average Change in Receivables over 5 years is -$12.2 million, with a median of $18.2 million recorded in 2022.
  • The sharpest annual moves came in 2022 and 2025: Change in Receivables soared 3361.22% in 2022, then plunged 1614.29% in 2025.
  • Over 5 years, Change in Receivables stood at $339.2 million in 2022, then tumbled by 124.0% to -$81.4 million in 2023, then sank by 269.16% to -$300.5 million in 2024, then rose by 9.52% to -$271.9 million in 2025, then surged by 146.52% to $126.5 million in 2026.
  • The last three Change in Receivables figures came in at $126.5 million (Q2 2026), $126.3 million (Q1 2026), and -$271.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Teva Pharmaceutical Industries 42.55 Bn 38.89 Bn 2.15 Bn 91.00 Mn
2 Viatris 19.15 Bn 18.26 Bn 1.46 Bn 126.50 Mn
3 Dr Reddys Laboratories 9.87 Bn 9.70 Bn 396.53 Mn -
4 Amneal Pharmaceuticals 5.45 Bn 5.32 Bn 334.51 Mn 169.78 Mn
5 Bausch Health Companies 2.33 Bn 492.63 Mn 2.10 Bn 70.00 Mn
6 Alvotech 1.51 Bn 1.36 Bn 2.56 Mn 1.24 Mn
7 Ani Pharmaceuticals 1.48 Bn 1.12 Bn 165.89 Mn 19.08 Mn
8 Amphastar Pharmaceuticals 992.90 Mn 702.78 Mn 93.47 Mn -2.98 Mn
9 Fennec Pharmaceuticals 401.76 Mn 360.51 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 126.50 Mn
Mar 31, 2026 126.30 Mn
Dec 31, 2025 -271.90 Mn
Sep 30, 2025 95.70 Mn
Jun 30, 2025 9.60 Mn
Mar 31, 2025 -168.00 Mn
Dec 31, 2024 -300.50 Mn
Sep 30, 2024 33.00 Mn
Jun 30, 2024 -22.80 Mn
Mar 31, 2024 -9.80 Mn
Dec 31, 2023 -81.40 Mn
Sep 30, 2023 72.00 Mn
Jun 30, 2023 145.80 Mn
Mar 31, 2023 -215.00 Mn
Dec 31, 2022 339.20 Mn
Sep 30, 2022 -241.20 Mn
Jun 30, 2022 26.80 Mn
Mar 31, 2022 115.50 Mn
Dec 31, 2021 9.80 Mn
Sep 30, 2021 -183.80 Mn